Literature DB >> 13129452

Cooking attenuates the ability of high-amylose meals to reduce plasma insulin concentrations in rats.

Marc A Brown1, Leonard H Storlien, Ian L Brown, Janine A Higgins.   

Abstract

Postprandial glycaemic control is important in the prevention and therapy of type 2 diabetes and related diseases. Agents that may reduce postprandial glycaemia and/or insulinaemia, such as consumption of high-amylose foods, are considered beneficial; however, little is known about the dose-response relationship and the effects of cooking. The aim of the present study was to define the dose-response curve for postprandial glycaemic and insulinaemic excursions following meals of different amylose content and to compare the dose-response curves for meals containing cooked and uncooked starches. Following an overnight fast, rats ingested a test meal and blood was sampled over 2 h. The meal was given at 1.0 g carbohydrate/kg body weight, with an amylose content of 0, 270, 600 or 850 g/kg total starch. The area under the glucose curve did not differ under any condition investigated. For the uncooked-starch diets, area under the insulin curve was higher for the 0 g amylose/kg total starch meal than all other meals (P=0.0001). For the cooked-starch diets, area under the insulin curve was higher in the 0 than the 600 and 850 g amylose/kg total starch groups (P<0.01), but did not differ from the 270 amylose/kg total starch group. These results suggest that even a relatively small proportion of uncooked amylose (270 g/kg total starch) is sufficient to achieve a maximal attenuating effect on postprandial insulin concentrations as compared with 0 g amylose/kg total starch. Following cooking, however, a much higher proportion of amylose (>or=600 g/kg total starch) is needed to achieve a similar effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129452     DOI: 10.1079/bjn2003958

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  8 in total

Review 1.  Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?

Authors:  Cristiane Moraes; Natália A Borges; Denise Mafra
Journal:  Eur J Nutr       Date:  2016-01-30       Impact factor: 5.614

2.  Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats.

Authors:  Julie M Clarke; Graeme P Young; David L Topping; Anthony R Bird; Lynne Cobiac; Benjamin L Scherer; Jessica G Winkler; Trevor J Lockett
Journal:  Carcinogenesis       Date:  2011-11-10       Impact factor: 4.944

3.  Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men.

Authors:  Kevin C Maki; Christine L Pelkman; E Terry Finocchiaro; Kathleen M Kelley; Andrea L Lawless; Arianne L Schild; Tia M Rains
Journal:  J Nutr       Date:  2012-02-22       Impact factor: 4.798

4.  Consumption of resistant starch decreases postprandial lipogenesis in white adipose tissue of the rat.

Authors:  Janine A Higgins; Marc A Brown; Leonard H Storlien
Journal:  Nutr J       Date:  2006-09-20       Impact factor: 3.271

5.  The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study.

Authors:  Somaye Fatahi; Mohammad Hassan Sohouli; Appaji Rayi; Farshad Teymoori; Farzad Shidfar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

6.  Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats.

Authors:  Julie M Clarke; David L Topping; Anthony R Bird; Graeme P Young; Lynne Cobiac
Journal:  Carcinogenesis       Date:  2008-08-13       Impact factor: 4.944

7.  Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial.

Authors:  Barbora de Courten; Maximilian Pj de Courten; Casper G Schalkwijk; Karen Z Walker; Josephine Forbes
Journal:  JMIR Res Protoc       Date:  2015-07-29

8.  Testing the carbohydrate-insulin model in mice: The importance of distinguishing primary hyperinsulinemia from insulin resistance and metabolic dysfunction.

Authors:  David S Ludwig; Cara B Ebbeling; Benjamin T Bikman; James D Johnson
Journal:  Mol Metab       Date:  2020-02-12       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.